Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.
Journal: British journal of cancer
Published: March 01, 2017
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.
Journal: Investigational new drugs
Published: October 22, 2014
Showing 1-2 of 2
Last Updated: 09/26/2026